Significant drop seen in first 10 years of cessation, continues to decrease as cessation time increases.
A review of durvalumab, an immune checkpoint inhibitor approved for the treatment of urothelial carcinoma.
Radiation therapy administered after surgery for advanced upper tract urothelial carcinoma improves cancer-specific and distant metastasis-free survival, a study found.
Compared with men receiving androgen deprivation therapy for prostate cancer, healthy men had a 98% decreased risk of overactive bladder, study finds.
This survey assessed the opinions of oncologists, urologists, and oncology nurses on the use of shared decision-making in older men with metastatic castration-resistant prostate cancer.